BetterScholar BetterScholar

E. Saiag

Journal of the American Medical Association, Rheumatology, The Lancet Microbe, Clinical Microbiology and Infection, British Journal of Haematology, Open Forum Infectious Diseases, Transplantation Proceedings Show more
8
Role
Title
Level Year L/R
🐜 Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers.
7 auth. Y. Angel, A. Spitzer, O. Henig, E. Saiag, E. Sprecher, H. Padova, ... R. Ben-Ami 		7 2021
7
🐜
🐜 Association of a Third Dose of BNT162b2 Vaccine With Incidence of SARS-CoV-2 Infection Among Health Care Workers in Israel.
38 auth. A. Spitzer, Y. Angel, Or Marudi, D. Zeltser, E. Saiag, H. Goldshmidt, I. Goldiner, M. Stark, Ora Halutz, R. Gamzu, M. Slobodkin, Nadav Amrami, E. Feigin, Meital Elbaz, M. Furman, ... Yotam Bronstein, Amanda Chikly, A. Eshkol, V. Furer, T. Mayer, Suzy E. Meijer, Ariel Melloul, M. Mizrahi, M. Yakubovsky, D. Rosenberg, Ari Safir, Liron Spitzer, Eyal Taleb, O. Elkayam, Adi Silberman, T. Eviatar, O. Elalouf, Tal Levinson, Katia Pozyuchenko, Ayelet Itzhaki-Alfia, E. Sprecher, R. Ben-Ami, O. Henig 		6 2022
6
🐜
🐜 Safety and immunogenicity of BNT162b2 mRNA COVID-19 vaccine in adolescents with rheumatic diseases treated with immunomodulatory medications
13 auth. M. Heshin‐Bekenstein, A. Ziv, N. Toplak, D. Hagin, D. Kadishevich, Y. Butbul, E. Saiag, Alla Kaufman, G. Shefer, O. Sharon, ... S. Pel, O. Elkayam, Y. Uziel 		5 2022
5
🐜
🦁 Immunogenicity of a BNT162b2 vaccine booster in health-care workers
E. Saiag, H. Goldshmidt, Eli Sprecher, R. Ben-Ami, D. Bomze 		4 2021
4
🦁
🦁 The effect of a third-dose BNT162b2 vaccine on anti-SARS-CoV-2 antibody levels in immunosuppressed patients
19 auth. E. Saiag, A. Grupper, I. Avivi, O. Elkayam, R. Ram, Y. Herishanu, Y. Cohen, C. Perry, V. Furer, H. Katchman, ... L. Rabinowich, M. Ben-Yehoyada, T. Halperin, R. Baruch, H. Goldshmidt, D. Hagin, R. Ben-Ami, Eli Sprecher, D. Bomze 		4 2022
4
🦁
🐜 BNT162b2 mRNA COVID‐19 vaccine booster induces seroconversion in patients with B‐cell non‐Hodgkin lymphoma who failed to respond to two prior vaccine doses
10 auth. I. Avivi, E. Luttwak, E. Saiag, T. Halperin, Shira Haberman, Ariel Sarig, ... S. Levi, A. Aharon, Y. Herishanu, C. Perry 		3 2022
3
🐜
🐜 Short-Term Safety of Booster Immunization With BNT162b2 mRNA COVID-19 Vaccine in Healthcare Workers
12 auth. Y. Paran, E. Saiag, A. Spitzer, Y. Angel, M. Yakubovsky, H. Padova, ... R. Ben-Ami, Ilana Goldinger, R. Gamzu, E. Sprecher, D. Zeltser, O. Henig 		3 2021
3
🐜
🐜 Humoral Response to the Third Dose of Sars-Cov-2 Vaccine in Kidney Transplant Recipients
20 auth. A. Grupper, L. Rabinowich, M. Ben-Yehoyada, E. Katchman, R. Baruch, Tal Freund, D. Hagin, S. B. Shlomo, D. Schwartz, I. Schwartz, ... Moshe Shashar, O. K. Bassat, T. Halperin, D. Turner, E. Saiag, Y. Goykhman, O. Shibolet, S. Levy, I. Houri, H. Katchman 		3 2022
3
🐜